MyFinsight
Home
Blog
About
Contact
Download
Download image
Total comprehensive
loss
-$6,453,685
(88.07%↑ Y/Y)
Net loss
-$6,360,336
(88.24%↑ Y/Y)
Total other
comprehensive income (gain)
-$93,349
(-241.80%↓ Y/Y)
Net loss
-$6,360,336
(88.24%↑ Y/Y)
Unrealized foreign
currency translation...
-$93,349
(-241.80%↓ Y/Y)
Change in fair value of
warrant liability
-$182,517
Other expense
$43,000
Foreign currency
transaction gain (loss)
$35,006
(380.36%↑ Y/Y)
Interest income
$13
(1200.00%↑ Y/Y)
Loss before taxes
-$6,360,336
(88.24%↑ Y/Y)
Total other income
(expense), net
$39,885
(104.25%↑ Y/Y)
Settlement expense
$90,000
Gain (loss) on
extinguishment of debt, net
-$74,235
(90.83%↑ Y/Y)
Interest expense
$38,270
(-63.22%↓ Y/Y)
Change in fair value of
derivative liabilities
-$18,146
(-138.51%↓ Y/Y)
Loss from operations
-$6,400,221
(87.95%↑ Y/Y)
Total operating
expenses
$6,400,221
(-87.95%↓ Y/Y)
Administration expenses
(including noncash...
$6,219,644
(-88.28%↓ Y/Y)
Research and development
$169,660
(213.62%↑ Y/Y)
Occupancy expenses -
related party
$10,917
(68.76%↑ Y/Y)
Back
Back
Income Statement
Propanc Biopharma, Inc. (PPCB)
Propanc Biopharma, Inc. (PPCB)
source: myfinsight.com